AI News NQ Analysis

Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026

Key facts

  • Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026
  • Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.
  • Source: PR TIMES
  • Date: Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)

Direct answer

Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.

Citation
Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026 (Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)), PR TIMES
Source
PR TIMES
Date
Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.

AI Analysis

Frequently Asked Questions

Q: What is the Metallo-Balance Test?
A: A screening test that analyzes 17 trace elements in blood to assess cancer and MCI risk.
Q: When does the test start at Anpo Clinic?
A: From July 24, 2026, every Friday and Saturday.
Q: How can I take the test?
A: Reserve via Renatech's website or hotline. No direct clinic contact.
Q: How much does the test cost?
A: Cancer or cognitive risk test: ¥19,800; both: ¥24,200 (tax included).
Q: Who can take the test?
A: Japanese nationals aged 20–80. Not for pregnant, cancer treatment, or dialysis patients.